Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura-Maria Krabbe

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Current Opinion in Urology|July 12, 2013
The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumorsNicholas G Cost, Laura-Maria Krabbe, Aditya Bagrodia, et al.
Expert Opinion on Biological Therapy|August 24, 2017
Prospects and progress of immunotherapy for bladder cancerMartin Boegemann, Ahmet Murat Aydin, Aditya Bagrodia, et al.
Seminars in Interventional Radiology|March 6, 2014
Surgical management of renal cell carcinomaLaura-Maria Krabbe, Aditya Bagrodia, Vitaly Margulis, et al.
Current Cancer Drug Targets|February 6, 2015
Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)Martin Boegemann, Andres-Jan Schrader, Laura-Maria Krabbe, et al.
Expert Review of Molecular Diagnostics|October 5, 2016
Improving diagnostic molecular tests to monitor urothelial carcinoma recurrenceLaura-Maria Krabbe, Solomon L Woldu, Shahrokh F Shariat, et al.
World Journal of Urology|April 5, 2014
Surgical management of metastatic renal cell carcinoma in the era of targeted therapiesLaura-Maria Krabbe, Ahmed Q Haddad, Mary E Westerman, et al.
Expert Review of Anticancer Therapy|January 20, 2016
The safety and efficacy of gemcitabine for the treatment of bladder cancerKatrin Schlack, Martin Boegemann, Julie Steinestel, et al.
Expert Review of Anticancer Therapy|June 1, 2018
Therapeutic strategies for upper tract urothelial carcinomaYuval Freifeld, Laura-Maria Krabbe, Timothy N Clinton, et al.
Urologic Oncology|July 22, 2014
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohortLaura-Maria Krabbe, Robert S Svatek, Shahrokh F Shariat, et al.
Nature Reviews. Urology|November 15, 2017
The Rho GTPase signalling pathway in urothelial carcinomaSolomon L Woldu, Ryan C Hutchinson, Laura-Maria Krabbe, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Current Opinion in Urology|July 12, 2013
The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumorsNicholas G Cost, Laura-Maria Krabbe, Aditya Bagrodia, et al.
Expert Opinion on Biological Therapy|August 24, 2017
Prospects and progress of immunotherapy for bladder cancerMartin Boegemann, Ahmet Murat Aydin, Aditya Bagrodia, et al.
Seminars in Interventional Radiology|March 6, 2014
Surgical management of renal cell carcinomaLaura-Maria Krabbe, Aditya Bagrodia, Vitaly Margulis, et al.
Current Cancer Drug Targets|February 6, 2015
Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)Martin Boegemann, Andres-Jan Schrader, Laura-Maria Krabbe, et al.
Expert Review of Molecular Diagnostics|October 5, 2016
Improving diagnostic molecular tests to monitor urothelial carcinoma recurrenceLaura-Maria Krabbe, Solomon L Woldu, Shahrokh F Shariat, et al.
World Journal of Urology|April 5, 2014
Surgical management of metastatic renal cell carcinoma in the era of targeted therapiesLaura-Maria Krabbe, Ahmed Q Haddad, Mary E Westerman, et al.
Expert Review of Anticancer Therapy|January 20, 2016
The safety and efficacy of gemcitabine for the treatment of bladder cancerKatrin Schlack, Martin Boegemann, Julie Steinestel, et al.
Expert Review of Anticancer Therapy|June 1, 2018
Therapeutic strategies for upper tract urothelial carcinomaYuval Freifeld, Laura-Maria Krabbe, Timothy N Clinton, et al.
Urologic Oncology|July 22, 2014
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohortLaura-Maria Krabbe, Robert S Svatek, Shahrokh F Shariat, et al.
Nature Reviews. Urology|November 15, 2017
The Rho GTPase signalling pathway in urothelial carcinomaSolomon L Woldu, Ryan C Hutchinson, Laura-Maria Krabbe, et al.
Pageof 10